Should dose-dense paclitaxel in combination with carboplatin be the new standard for treatment for suboptimally debulked patients or patients treated with neoadjuvant chemotherapy?

Marilyn Huang, Robert L. Coleman

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)51-52
Number of pages2
JournalClinical Ovarian and other Gynecologic Cancer
Volume5
Issue number2
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Carboplatin
Paclitaxel
Ovarian Neoplasms
Drug Therapy
Therapeutics

Keywords

  • Metronomic chemo
  • Ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

@article{efd9f964cd8644d3b24569f2c6f4cefe,
title = "Should dose-dense paclitaxel in combination with carboplatin be the new standard for treatment for suboptimally debulked patients or patients treated with neoadjuvant chemotherapy?",
keywords = "Metronomic chemo, Ovarian cancer",
author = "Marilyn Huang and Coleman, {Robert L.}",
year = "2012",
month = "12",
doi = "10.1016/j.cogc.2013.12.002",
language = "English (US)",
volume = "5",
pages = "51--52",
journal = "Clinical Ovarian Cancer",
issn = "2212-9553",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Should dose-dense paclitaxel in combination with carboplatin be the new standard for treatment for suboptimally debulked patients or patients treated with neoadjuvant chemotherapy?

AU - Huang, Marilyn

AU - Coleman, Robert L.

PY - 2012/12

Y1 - 2012/12

KW - Metronomic chemo

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84893909275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893909275&partnerID=8YFLogxK

U2 - 10.1016/j.cogc.2013.12.002

DO - 10.1016/j.cogc.2013.12.002

M3 - Article

AN - SCOPUS:84893909275

VL - 5

SP - 51

EP - 52

JO - Clinical Ovarian Cancer

JF - Clinical Ovarian Cancer

SN - 2212-9553

IS - 2

ER -